125 related articles for article (PubMed ID: 37466057)
21. Whole exome sequencing identified a novel
Li Y; Xie Y; Wang D; Xu H; Ye J; Yin JC; Chen J; Yan J; Ye B; Chen C
Front Oncol; 2022; 12():963364. PubMed ID: 36387164
[TBL] [Abstract][Full Text] [Related]
22. Loss-of-function variants in
Nathan V; Palmer JM; Johansson PA; Hamilton HR; Warrier SK; Glasson W; McGrath LA; Kahl VFS; Vasireddy RS; Pickett HA; Brooks KM; Pritchard AL; Hayward NK
J Med Genet; 2021 Apr; 58(4):234-236. PubMed ID: 32907878
[No Abstract] [Full Text] [Related]
23. Up-Front Multigene Panel Testing for Cancer Susceptibility in Patients With Newly Diagnosed Endometrial Cancer: A Multicenter Prospective Study.
Levine MD; Pearlman R; Hampel H; Cosgrove C; Cohn D; Chassen A; Suarez A; Barrington DA; McElroy JP; Waggoner S; Nakayama J; Billingsley C; Resnick K; Andrews S; Singh S; Jenison E; Clements A; Neff R; Goodfellow PJ;
JCO Precis Oncol; 2021 Nov; 5():1588-1602. PubMed ID: 34994648
[TBL] [Abstract][Full Text] [Related]
24. Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast.
Yadav S; Hu C; Nathanson KL; Weitzel JN; Goldgar DE; Kraft P; Gnanaolivu RD; Na J; Huang H; Boddicker NJ; Larson N; Gao C; Yao S; Weinberg C; Vachon CM; Trentham-Dietz A; Taylor JA; Sandler DR; Patel A; Palmer JR; Olson JE; Neuhausen S; Martinez E; Lindstrom S; Lacey JV; Kurian AW; John EM; Haiman C; Bernstein L; Auer PW; Anton-Culver H; Ambrosone CB; Karam R; Chao E; Yussuf A; Pesaran T; Dolinsky JS; Hart SN; LaDuca H; Polley EC; Domchek SM; Couch FJ
J Clin Oncol; 2021 Dec; 39(35):3918-3926. PubMed ID: 34672684
[TBL] [Abstract][Full Text] [Related]
25. Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma.
Abdel-Rahman MH; Sample KM; Pilarski R; Walsh T; Grosel T; Kinnamon D; Boru G; Massengill JB; Schoenfield L; Kelly B; Gordon D; Johansson P; DeBenedictis MJ; Singh A; Casadei S; Davidorf FH; White P; Stacey AW; Scarth J; Fewings E; Tischkowitz M; King MC; Hayward NK; Cebulla CM
Ophthalmology; 2020 May; 127(5):668-678. PubMed ID: 32081490
[TBL] [Abstract][Full Text] [Related]
26. Significance of the Multi-gene Panel myRisk in Japan.
Hayashi S; Kubo M; Matsuzaki S; Kai M; Morisaki T; Yamada M; Kaneshiro K; Takao Y; Shimazaki A; Nagayoshi K; Mizuuchi Y; Nakamura M
Anticancer Res; 2022 Aug; 42(8):4097-4102. PubMed ID: 35896222
[TBL] [Abstract][Full Text] [Related]
27. The wide spectrum of POT1 gene variants correlates with multiple cancer types.
Calvete O; Garcia-Pavia P; Domínguez F; Bougeard G; Kunze K; Braeuninger A; Teule A; Lasa A; Ramón Y Cajal T; Llort G; Fernández V; Lázaro C; Urioste M; Benitez J
Eur J Hum Genet; 2017 Nov; 25(11):1278-1281. PubMed ID: 28853721
[TBL] [Abstract][Full Text] [Related]
28. A Truncating Germline Mutation of
He H; Li W; Comiskey DF; Liyanarachchi S; Nieminen TT; Wang Y; DeLap KE; Brock P; de la Chapelle A
Thyroid; 2020 Feb; 30(2):204-213. PubMed ID: 31928178
[No Abstract] [Full Text] [Related]
29.
Jensen MR; Jelsig AM; Gerdes AM; Hölmich LR; Kainu KH; Lorentzen HF; Hansen MH; Bak M; Johansson PA; Hayward NK; Van Overeem Hansen T; Wadt KAW
HGG Adv; 2023 Oct; 4(4):100225. PubMed ID: 37646013
[No Abstract] [Full Text] [Related]
30. Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non-CDKN2A/CDK4 melanoma families.
Potjer TP; Bollen S; Grimbergen AJEM; van Doorn R; Gruis NA; van Asperen CJ; Hes FJ; van der Stoep N;
Int J Cancer; 2019 May; 144(10):2453-2464. PubMed ID: 30414346
[TBL] [Abstract][Full Text] [Related]
31. Lack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer.
Orois A; Badenas C; Reverter JL; López V; Potrony M; Mora M; Halperin I; Oriola J
Horm Cancer; 2020 Apr; 11(2):111-116. PubMed ID: 32172474
[TBL] [Abstract][Full Text] [Related]
32. Germline POT1 variants can predispose to myeloid and lymphoid neoplasms.
Lim TL; Lieberman DB; Davis AR; Loren AW; Hausler R; Bigdeli A; Li Y; Powers J; Raper A; Regeneron Genetics Center ; Carty SA; Nathanson KL; Bagg A; Hexner EO; Maxwell KN; Morrissette JJD; Babushok DV
Leukemia; 2022 Jan; 36(1):283-287. PubMed ID: 34193977
[No Abstract] [Full Text] [Related]
33. Should all patients undergoing genetic testing for hereditary breast cancer syndromes be offered a multigene panel?
Silver EL; Niell-Swiller M
Curr Opin Obstet Gynecol; 2022 Feb; 34(1):36-40. PubMed ID: 34967813
[TBL] [Abstract][Full Text] [Related]
34. Impact of Gln94Glu mutation on the structure and function of protection of telomere 1, a cause of cutaneous familial melanoma.
Amir M; Ahmad S; Ahamad S; Kumar V; Mohammad T; Dohare R; Alajmi MF; Rehman T; Hussain A; Islam A; Ahmad F; Hassan MI
J Biomol Struct Dyn; 2020 Mar; 38(5):1514-1524. PubMed ID: 31014199
[TBL] [Abstract][Full Text] [Related]
35. Universal germline testing among patients with colorectal cancer: clinical actionability and optimised panel.
Jiang W; Li L; Ke CF; Wang W; Xiao BY; Kong LH; Tang JH; Li Y; Wu XD; Hu Y; Guo WH; Wang SZ; Wan DS; Xu RH; Pan ZZ; Ding PR
J Med Genet; 2022 Apr; 59(4):370-376. PubMed ID: 33563768
[TBL] [Abstract][Full Text] [Related]
36. Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care-Checking CHEK2.
Bychkovsky BL; Agaoglu NB; Horton C; Zhou J; Yussuf A; Hemyari P; Richardson ME; Young C; LaDuca H; McGuinness DL; Scheib R; Garber JE; Rana HQ
JAMA Oncol; 2022 Nov; 8(11):1598-1606. PubMed ID: 36136322
[TBL] [Abstract][Full Text] [Related]
37. Investigation of conformational dynamics of Tyr89Cys mutation in protection of telomeres 1 gene associated with familial melanoma.
Amir M; Ahamad S; Mohammad T; Jairajpuri DS; Hasan GM; Dohare R; Islam A; Ahmad F; Hassan MI
J Biomol Struct Dyn; 2021 Jan; 39(1):35-44. PubMed ID: 31847782
[TBL] [Abstract][Full Text] [Related]
38. Dissecting Fission Yeast Shelterin Interactions via MICro-MS Links Disruption of Shelterin Bridge to Tumorigenesis.
Liu J; Yu C; Hu X; Kim JK; Bierma JC; Jun HI; Rychnovsky SD; Huang L; Qiao F
Cell Rep; 2015 Sep; 12(12):2169-80. PubMed ID: 26365187
[TBL] [Abstract][Full Text] [Related]
39. Frequent Mutations of POT1 Distinguish Pulmonary Sarcomatoid Carcinoma From Other Lung Cancer Histologies.
Shen E; Xiu J; Bentley R; López GY; Walsh KM
Clin Lung Cancer; 2020 Nov; 21(6):e523-e527. PubMed ID: 32414627
[TBL] [Abstract][Full Text] [Related]
40. Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia.
Speedy HE; Kinnersley B; Chubb D; Broderick P; Law PJ; Litchfield K; Jayne S; Dyer MJS; Dearden C; Follows GA; Catovsky D; Houlston RS
Blood; 2016 Nov; 128(19):2319-2326. PubMed ID: 27528712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
